Showing results (141-150 of 366) with videos related to
Sort By:
Pageof 37
Urology|December 8, 2009
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?William K Oh, Mary Beth Landrum, Elizabeth B Lamont, et al.Cancer|November 11, 2011
Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health AdministrationMary Beth Landrum, Nancy L Keating, Elizabeth B Lamont, et al.Archives of Internal Medicine|May 12, 2004
Patient characteristics and experiences associated with trust in specialist physiciansNancy L Keating, Tejal K Gandhi, E John Orav, et al.JAMA Network Open|January 4, 2020
Association of Physician Peer Influence With Subsequent Physician Adoption and Use of BevacizumabNancy L Keating, A James O'Malley, Jukka-Pekka Onnela, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2013
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemiaStacie B Dusetzina, Aaron N Winn, Gregory A Abel, et al.Breast Cancer Research and Treatment|January 29, 2018
Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare RegistryMark Fairweather, Wei Jiang, Nancy L Keating, et al.JAMA Internal Medicine|May 1, 2018
Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance HemodialysisMelissa W Wachterman, Susan M Hailpern, Nancy L Keating, et al.Medical Care|March 23, 2012
Area-level variations in cancer care and outcomesNancy L Keating, Mary Beth Landrum, Elizabeth B Lamont, et al.BJU International|January 15, 2008
Use of androgen deprivation therapy for metastatic prostate cancer in older menNancy L Keating, A James O'Malley, Mary McNaughton-Collins, et al.Psychiatric Services (Washington, D.C.)|February 28, 2007
Coverage and prior authorization of psychotropic drugs under Medicare Part DHaiden A Huskamp, David G Stevenson, Julie M Donohue, et al.Pageof 37